The role of oxidative stress in hyperuricemia and xanthine oxidoreductase (XOR) inhibitors

N Liu, H Xu, Q Sun, X Yu, W Chen… - Oxidative Medicine …, 2021 - Wiley Online Library
Uric acid is the end product of purine metabolism in humans. Hyperuricemia is a metabolic
disease caused by the increased formation or reduced excretion of serum uric acid (SUA) …

Characteristic dysbiosis in gout and the impact of a uric acid-lowering treatment, febuxostat on the gut microbiota

S Lin, T Zhang, L Zhu, K Pang, S Lu, X Liao… - Journal of Genetics and …, 2021 - Elsevier
Gut dysbiosis is suggested to play a critical role in the pathogenesis of gout. The aim of our
study was to identify the characteristic dysbiosis of the gut microbiota in gout patients and …

[HTML][HTML] Optimization of culture medium for Sanghuangporus vaninii and a study on its therapeutic effects on gout

Q Guo, L Zhao, Y Zhu, J Wu, C Hao, S Song… - Biomedicine & …, 2021 - Elsevier
The increasing incidence of gout poses a very challenging management problem. However,
the currently available drugs often have various toxic side effects. As a traditional edible and …

Management of hypertension addressing hyperuricaemia: introduction of nano-based approaches

K Girigoswami, R Arunkumar, A Girigoswami - Annals of Medicine, 2024 - Taylor & Francis
Uric acid (UA) levels in blood serum have been associated with hypertension, indicating a
potential causal relationship between high serum UA levels and the progression of …

Xanthine dehydrogenase downregulation promotes TGFβ signaling and cancer stem cell-related gene expression in hepatocellular carcinoma

GL Chen, T Ye, HL Chen, ZY Zhao, WQ Tang, LS Wang… - Oncogenesis, 2017 - nature.com
Xanthine dehydrogenase (XDH), a rate-limiting enzyme involved in purine metabolism, has
an essential role in inflammatory cascades. Researchers have known for decades that XDH …

Design, synthesis and biological evaluation of N-(4-alkoxy-3-(1H-tetrazol-1-yl) phenyl) heterocyclic aromatic amide derivatives as xanthine oxidase inhibitors

T Zhang, Z Zhang, X Zhang, Z Wang, E Xu, S Tu… - Bioorganic …, 2022 - Elsevier
Xanthine oxidase (XO) is a flavoprotein that exists in various organisms and can catalyze the
uric acid formation in the human body. Based on the amide framework of N-(4-((3 …

Xanthine oxidoreductase is involved in chondrocyte mineralization and expressed in osteoarthritic damaged cartilage

S Nasi, M Castelblanco, V Chobaz… - Frontiers in Cell and …, 2021 - frontiersin.org
Pathologic calcification of cartilage consists of the formation of basic calcium phosphate
(BCP) and/or calcium pyrophosphate dihydrate (CPPD) containing calcium crystals in …

Metabolic dysfunctions in the kynurenine pathway, noradrenergic and purine metabolism in schizophrenia and bipolar disorders

NE Steen, I Dieset, S Hope, TSJ Vedal… - Psychological …, 2020 - cambridge.org
BackgroundWe aimed at exploring potential pathophysiological processes across psychotic
disorders, applying metabolomics in a large and well-characterized sample of patients and …

Lysinibacillus fusiformis M5 induces increased complexity in Bacillus subtilis 168 colony biofilms via hypoxanthine

R Gallegos-Monterrosa, S Kankel, S Götze… - Journal of …, 2017 - Am Soc Microbiol
In recent years, biofilms have become a central subject of research in the fields of
microbiology, medicine, agriculture, and systems biology, among others. The …

Xanthine oxidase inhibitor febuxostat reduces atrial fibrillation susceptibility by inhibition of oxidized CaMKII in Dahl salt-sensitive rats

DZ Xu, N Murakoshi, K Tajiri, F Duo, Y Okabe… - Clinical …, 2021 - portlandpress.com
Oxidative stress could be a possible mechanism and a therapeutic target of atrial fibrillation
(AF). However, the effects of the xanthine oxidase (XO) inhibition for AF remain to be fully …